Cargando…
Increased Plasma Heparanase Activity in COVID-19 Patients
Reports suggest a role of endothelial dysfunction and loss of endothelial barrier function in COVID-19. It is well established that the endothelial glycocalyx-degrading enzyme heparanase contributes to vascular leakage and inflammation. Low molecular weight heparins (LMWH) serve as an inhibitor of h...
Autores principales: | Buijsers, Baranca, Yanginlar, Cansu, de Nooijer, Aline, Grondman, Inge, Maciej-Hulme, Marissa L., Jonkman, Inge, Janssen, Nico A. F., Rother, Nils, de Graaf, Mark, Pickkers, Peter, Kox, Matthijs, Joosten, Leo A. B., Nijenhuis, Tom, Netea, Mihai G., Hilbrands, Luuk, van de Veerdonk, Frank L., Duivenvoorden, Raphaël, de Mast, Quirijn, van der Vlag, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573491/ https://www.ncbi.nlm.nih.gov/pubmed/33123154 http://dx.doi.org/10.3389/fimmu.2020.575047 |
Ejemplares similares
-
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
por: Buijsers, Baranca, et al.
Publicado: (2020) -
Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons
por: Rother, Nils, et al.
Publicado: (2020) -
Microparticles in Autoimmunity: Cause or Consequence of Disease?
por: Rother, Nils, et al.
Publicado: (2022) -
Neutrophils Discriminate between Lipopolysaccharides of Different Bacterial Sources and Selectively Release Neutrophil Extracellular Traps
por: Pieterse, Elmar, et al.
Publicado: (2016) -
Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy
por: Buijsers, Baranca, et al.
Publicado: (2023)